PMID: 2486181Mar 1, 1989Paper

Ketamine for intravenous regional anesthesia

Anesthesia and Analgesia
Z DurraniM L Burnett

Abstract

We studied ketamine intravenous regional anesthesia of the upper extremity in volunteers using concentrations of 0.5%, 0.3%, and 0.2%. Ketamine 0.5 and 0.3% produced adequate intravenous regional anesthesia. Anesthesia was inadequate when a 0.2% concentration was used. However, although the 0.3% concentration provides complete sympathetic, sensory, and motor blockade when injected into the isolated extremity, unpleasant psychotomimetic effects after the release of the tourniquet limit the usefulness of this use of ketamine. Ketamine cannot be recommended for intravenous regional anesthesia unless these unpleasant side effects are abolished or controlled by means of pharmacologic adjuvants.

Citations

Sep 29, 2005·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Yatindra Kumar BatraMandeep Singh Dhillon
Oct 10, 2002·Regional Anesthesia and Pain Medicine·Takahiro UshidaHiroshi Yamamoto
Feb 1, 1995·Acta Anaesthesiologica Scandinavica·K HirotaS F Rabito
Dec 5, 1997·Veterinary Surgery : VS·D D MartinG J Benson
May 30, 2007·Clinical Drug Investigation·Yoshitaka Fujii, Masahiro Nakayama
Dec 12, 2012·Journal of Anaesthesiology, Clinical Pharmacology·Alok KumarBarun Datta
Oct 12, 2010·Saudi Journal of Anaesthesia·Khaled Fawzy ElmetwalyAhmad Abdullah Alshaer
Jan 27, 2004·Medicinski pregled·Dragana Radovanović, Miroslava Pjević
Oct 17, 2008·Gastrointestinal Endoscopy Clinics of North America·Mark H Delegge
Aug 8, 2007·Gastroenterology·Lawrence B CohenUNKNOWN AGA Institute
Dec 17, 2003·Acta Anaesthesiologica Scandinavica·S BrillA Fisher
May 15, 2013·CNS Neuroscience & Therapeutics·Jan Persson
Jul 17, 1998·Anesthesiology·J L PedersenH Kehlet
Jul 30, 2014·Regional Anesthesia and Pain Medicine·Hala S Abdel-GhaffarAhmed Said Imbaby
May 23, 2012·The American Journal of Gastroenterology·John J VargoLawrence R Schiller
Feb 19, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Neil S BailardRoland A Flores
Apr 9, 2005·European Journal of Anaesthesiology·Y K BatraA Agzamov
Sep 24, 2002·European Journal of Anaesthesiology·G ReckziegelB W Urban
Jul 31, 2003·Journal of Veterinary Pharmacology and Therapeutics·J López-SanrománF J Tendillo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality
Susan C Boisvert
International Anesthesiology Clinics
M F Watcha, P F White
© 2022 Meta ULC. All rights reserved